OTCMKTS:KHRNF Khiron Life Sciences - KHRNF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. $0.11 -0.01 (-8.62%) (As of 02/2/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.10▼$0.1150-Day Range$0.04▼$0.1252-Week Range$0.03▼$0.22Volume446,630 shsAverage Volume327,006 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About Khiron Life Sciences (OTCMKTS:KHRNF) StockKhiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. It provides medical cannabis in Colombia and focuses on the cultivation, production, international export, domestic distribution and sale of THC (tetrahydrocannabinol) medical cannabis products. The firm operates through the following segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The Medical Cannabis Products segment involves in growth, production and sale of branded products and services to patients with medical conditions where cannabis can be an acceptable, proven option. The Health Services segment operates its medium complexity health centers offering a suite of health, medical and surgical services in alignment with insurance company partners. The Wellbeing Products segment focuses on delivering the benefits of CBD and hemp across an array of various branded consumer packaged goods, such as Kuida cosmetics line. The company was founded by Álvaro F. Torres on May 16, 2012 and is headquartered in Vancouver, Canada.Read More Receive KHRNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address KHRNF Stock News HeadlinesJanuary 18, 2023 | proactiveinvestors.comKhiron Life Sciences shares growth in medical cannabis field throughout South America and EuropeJanuary 9, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron wins first medical cannabis contract with Colombia's largest public insurance companyFebruary 3, 2023 | Investing Trends (Ad)Apple, Amazon, and Walmart are Investing in Solar EnergyThe global market for solar energy is expected to be worth an astronomical $1 trillion by the end of 2028, with increasing adoption of solar by commercial, non-profit, and public entities. Even Fortune 500 companies such as Apple, Amazon, and Walmart are investing in solar to help save money over the long term. So it's little wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.December 1, 2022 | finance.yahoo.comKhiron Life Sciences Third Quarter 2022 Earnings: CA$0.017 loss per share (vs CA$0.019 loss in 3Q 2021)November 30, 2022 | seekingalpha.comKhiron Life Sciences Corp. (KHRNF) Q3 2022 Earnings Call TranscriptNovember 30, 2022 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron Life Sciences Reports Third Quarter 2022 Financial ResultsNovember 30, 2022 | finance.yahoo.comKhiron Life Sciences Reports Third Quarter 2022 Financial ResultsNovember 18, 2022 | finance.yahoo.comKhiron to Host Third Quarter 2022 Conference Call on November 30, 2022February 3, 2023 | Investing Trends (Ad)Elon Musk Claims Solar Will Soon Power the WorldThe world's wealthiest person -- Elon Musk -- is a visionary investor. And he fully expects solar power to be our #1 energy source within a few decades. Utility-scale solar is already becoming the cheapest option for electricity generation globally. So with the push toward clean, renewable energy, it's no wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.November 16, 2022 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United KingdomNovember 16, 2022 | benzinga.comKhiron Launches Cannabis Flower Products In SwitzerlandOctober 28, 2022 | msn.com15 Global Psychedelics Executives To Keep An Eye On In 2022September 14, 2022 | benzinga.comKhiron Life Sciences Awarded Best Latin American...September 13, 2022 | finance.yahoo.comKhiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital ConferenceSeptember 1, 2022 | benzinga.comMedical Cannabis Company Khiron Launching New Products In EuropeAugust 29, 2022 | msn.comKhiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In GermanyAugust 29, 2022 | finance.yahoo.comKhiron Life Sciences Reports Second Quarter 2022 Financial ResultsAugust 22, 2022 | finance.yahoo.comKhiron to Host Second Quarter 2022 Conference Call on August 29, 2022August 9, 2022 | finance.yahoo.comMedical Cannabis Leader Khiron Opens Brazil's First Zerenia™ ClinicAugust 3, 2022 | proactiveinvestors.comPharmaDrug closes sale of German cannabis assets to Khiron Life SciencesJuly 18, 2022 | finance.yahoo.comKhiron Appoints Helen Bellwood (ACA) as Interim CFOJuly 6, 2022 | finance.yahoo.comMedical Cannabis Leader Khiron Continues Global Expansion into SpainJune 23, 2022 | finance.yahoo.comKhiron Announces Results of 2022 Annual General and Special MeetingJune 10, 2022 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES CLOSING OF $4.6 MILLION OVERNIGHT BROKERED OFFERING INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTIONJune 1, 2022 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT BROKERED OFFERINGMay 31, 2022 | proactiveinvestors.comPharmaDrug agrees to sell German cannabis distribution subsidiary in exchange for equity in Khiron Life Sciences and $1.1M promissory noteMay 25, 2022 | finance.yahoo.comKhiron to Host First Quarter 2022 Conference Call on May 31, 2022See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive KHRNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:KHRNF CUSIPN/A CIKN/A Webwww.khiron.ca Phone(702) 527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesÁlvaro F. TorresChief Executive Officer & DirectorManuel BuendiaVice President-OperationsHelen BellwoodChief Financial OfficerJairo EspinozaVice President-Medical AffairsMatt MurphyVice President-ComplianceKey Competitors1933 IndustriesOTCMKTS:TGIFF4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFAcreageOTCMKTS:ACRHFView All Competitors KHRNF Stock - Frequently Asked Questions Should I buy or sell Khiron Life Sciences stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KHRNF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KHRNF, but not buy additional shares or sell existing shares. View KHRNF analyst ratings or view top-rated stocks. How have KHRNF shares performed in 2023? Khiron Life Sciences' stock was trading at $0.0415 at the beginning of the year. Since then, KHRNF stock has increased by 155.4% and is now trading at $0.1060. View the best growth stocks for 2023 here. Are investors shorting Khiron Life Sciences? Khiron Life Sciences saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 120,000 shares, an increase of 46.9% from the December 31st total of 81,700 shares. Based on an average trading volume of 807,600 shares, the days-to-cover ratio is presently 0.1 days. View Khiron Life Sciences' Short Interest. What is Khiron Life Sciences' stock symbol? Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF." How do I buy shares of Khiron Life Sciences? Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Khiron Life Sciences' stock price today? One share of KHRNF stock can currently be purchased for approximately $0.11. How can I contact Khiron Life Sciences? Khiron Life Sciences' mailing address is 500 Burrard Street, Vancouver, BC V6C. The official website for the company is www.khiron.ca. The company can be reached via phone at (702) 527-3564. This page (OTCMKTS:KHRNF) was last updated on 2/3/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.